132 related articles for article (PubMed ID: 15981922)
21. A functional assay for quantitation of the apparent affinities of ligands of P-glycoprotein in Caco-2 cells.
Gao J; Murase O; Schowen RL; Aubé J; Borchardt RT
Pharm Res; 2001 Feb; 18(2):171-6. PubMed ID: 11405287
[TBL] [Abstract][Full Text] [Related]
22. Enhancement of paclitaxel transport and cytotoxicity by 7,3',4'-trimethoxyflavone, a P-glycoprotein inhibitor.
Jeong JM; Choi CH
J Pharm Pharm Sci; 2007; 10(4):547-53. PubMed ID: 18261374
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of an acyloxyalkoxy-based cyclic prodrug of the opioid peptide DADLE.
Tang F; Borchardt RT
Pharm Res; 2002 Jun; 19(6):780-6. PubMed ID: 12134947
[TBL] [Abstract][Full Text] [Related]
24. Mechanistic roles of neutral surfactants on concurrent polarized and passive membrane transport of a model peptide in Caco-2 cells.
Nerurkar MM; Ho NF; Burton PS; Vidmar TJ; Borchardt RT
J Pharm Sci; 1997 Jul; 86(7):813-21. PubMed ID: 9232522
[TBL] [Abstract][Full Text] [Related]
25. Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of the coumarinic acid-based cyclic prodrug of the opioid peptide DADLE.
Tang F; Borchardt RT
Pharm Res; 2002 Jun; 19(6):787-93. PubMed ID: 12134948
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of transport and structure-permeability relationship of sulfasalazine and its analogs in Caco-2 cell monolayers.
Liang E; Proudfoot J; Yazdanian M
Pharm Res; 2000 Oct; 17(10):1168-74. PubMed ID: 11145220
[TBL] [Abstract][Full Text] [Related]
27. Transport and metabolism of MitoQ10, a mitochondria-targeted antioxidant, in Caco-2 cell monolayers.
Li Y; Fawcett JP; Zhang H; Tucker IG
J Pharm Pharmacol; 2007 Apr; 59(4):503-11. PubMed ID: 17430633
[TBL] [Abstract][Full Text] [Related]
28. Involvement of P-glycoprotein and multidrug resistance associated protein 1 on the transepithelial transport of a mercaptoacetamide-based histone-deacetylase inhibitor in Caco-2 cells.
Konsoula Z; Jung M
Biol Pharm Bull; 2009 Jan; 32(1):74-8. PubMed ID: 19122284
[TBL] [Abstract][Full Text] [Related]
29. Evidence for a polarized efflux system in CACO-2 cells capable of modulating cyclosporin A transport.
Augustijns PF; Bradshaw TP; Gan LS; Hendren RW; Thakker DR
Biochem Biophys Res Commun; 1993 Dec; 197(2):360-5. PubMed ID: 7903526
[TBL] [Abstract][Full Text] [Related]
30. Rhodamine 123 requires carrier-mediated influx for its activity as a P-glycoprotein substrate in Caco-2 cells.
Troutman MD; Thakker DR
Pharm Res; 2003 Aug; 20(8):1192-9. PubMed ID: 12948017
[TBL] [Abstract][Full Text] [Related]
31. Transepithelial transport mechanisms of 7,8-dihydroxyflavone, a small molecular TrkB receptor agonist, in human intestinal Caco-2 cells.
Chen Y; Xue F; Xia G; Zhao Z; Chen C; Li Y; Zhang Y
Food Funct; 2019 Aug; 10(8):5215-5227. PubMed ID: 31384856
[TBL] [Abstract][Full Text] [Related]
32. Validation and application of Caco-2 assays for the in vitro evaluation of development candidate drugs as substrates or inhibitors of P-glycoprotein to support regulatory submissions.
Elsby R; Surry DD; Smith VN; Gray AJ
Xenobiotica; 2008 Jul; 38(7-8):1140-64. PubMed ID: 18668443
[TBL] [Abstract][Full Text] [Related]
33. Active efflux kinetics of etoposide from rabbit small intestine and colon.
Kunta J; Yan J; Makhey VD; Sinko PJ
Biopharm Drug Dispos; 2000 Apr; 21(3):83-93. PubMed ID: 11113881
[TBL] [Abstract][Full Text] [Related]
34. A biophysical model of passive and polarized active transport processes in Caco-2 cells: approaches to uncoupling apical and basolateral membrane events in the intact cell.
Ho NF; Burton PS; Conradi RA; Barsuhn CL
J Pharm Sci; 1995 Jan; 84(1):21-7. PubMed ID: 7714738
[TBL] [Abstract][Full Text] [Related]
35. Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers.
Rege BD; Kao JP; Polli JE
Eur J Pharm Sci; 2002 Sep; 16(4-5):237-46. PubMed ID: 12208453
[TBL] [Abstract][Full Text] [Related]
36. Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting.
Dahan A; Amidon GL
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G371-7. PubMed ID: 19541926
[TBL] [Abstract][Full Text] [Related]
37. Transport of thalidomide by the human intestinal caco-2 monolayers.
Zhou S; Li Y; Kestell P; Schafer P; Chan E; Paxton JW
Eur J Drug Metab Pharmacokinet; 2005; 30(1-2):49-61. PubMed ID: 16010862
[TBL] [Abstract][Full Text] [Related]
38. Isolation and characterization of Caco-2 subclones expressing high levels of multidrug resistance protein efflux transporter.
Horie K; Tang F; Borchardt RT
Pharm Res; 2003 Feb; 20(2):161-8. PubMed ID: 12636153
[TBL] [Abstract][Full Text] [Related]
39. Transport and epithelial secretion of the cardiac glycoside, digoxin, by human intestinal epithelial (Caco-2) cells.
Cavet ME; West M; Simmons NL
Br J Pharmacol; 1996 Jul; 118(6):1389-96. PubMed ID: 8832062
[TBL] [Abstract][Full Text] [Related]
40. Secretory transport of methylprednisolone possibly mediated by P-glycoprotein in Caco-2 cells.
Oka A; Oda M; Saitoh H; Nakayama A; Takada M; Aungst BJ
Biol Pharm Bull; 2002 Mar; 25(3):393-6. PubMed ID: 11913542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
